Healthcare Innovation July 29, 2024
Randall discusses Level2, a value-based care program that combines continuous glucose monitoring with customized clinical support for people living with Type 2 diabetes
UnitedHealthcare’s Level2 is a value-based care program that combines wearable technology with customized clinical support to help improve the health of people living with Type 2 diabetes. Rhonda Randall, D.O., chief medical officer for UnitedHealthcare’s commercial business, recently spoke with Healthcare Innovation about data presented at the 2024 American Diabetes Conference on Level2’s new “Assured Value Program,” which aims to ensure eligible employers realize value with the program.
Healthcare Innovation: Before we talk about the Level2 program, could you give us a little bit of detail about your background and what your role as chief medical officer...
Today's Sponsors
Today's Sponsor